TB Online is no longer maintained. This is an archive of the site. For news on TB please go to:
https://globaltbcab.org/
Once-daily dolutegravir sufficient when taking TB treatment
Keith Alcorn
June 16, 2023, 1:37 p.m.
A second daily dose of dolutegravir for people taking standard TB treatment seems to be unnecessary, a South African randomised study has reported in the journal Lancet HIV.
Read the full article at Aidsmap.